Global Liquid Biopsy Market Survey, Trend Analysis and Opportunity As April 2017 | Page 2

Global Liquid Biopsy Market According to the report "Liquid Biopsy Market", published by Market Data Forecast, the global market is projected to reach USD 1.75 Billion by 2021, at a CAGR of 24.3% from 2016 to 2021. Liquid biopsies have been an advancement in cancer treatment. By means of a simple blood draw, liquid biopsies aim to replace needle biopsies of solid tumours, which can be expensive for the healthcare system as well as invasive and painful for patients. Liquid biopsies are a sequencing-based technology used to screen blood for tiny fragments of genetic material released by cancer tissue Liquid biopsies have grown in importance because, the genetic profile of tumours can affect how well they respond to a certain treatment. Increasing prevalence of various cancers such as lung cancer, breast cancer and prostate cancer is expected to drive growth of the liquid biopsy test market over the forecast period. Global Market for Liquid Biopsy is segmented by type of cancer, sample type, diagnostic approach, end users and region By Cancer Type:     Lung Cancer Pancreatic Cancer Leukemia Other Visceral Cancers By Sample Type:      Blood Urine Plasma Saliva Cerebrospinal By Diagnostic Approach:     Circulating Tumour cells (CTC) Circulating Tumour DNA (ctDNA) RNA in exosomes Extra-Cellular Vesicles By End Users:     Reference Laboratories Hospital/Physician Laboratories Academic and Research Centers Other End Users By Geography:  North America [phone] | www.marketdataforecast.com | [email protected]